Posts Tagged ‘FDA draft guidance’

REMS Assessments: Designing and Evaluating REMS

Wednesday, May 26th, 2010

Sponsors are struggling with how to adapt research survey methods to meet the regulatory reporting standards of REMS assessments.  Assessments need to be designed in a way that measure risk mitigation.  Reports and interpretation of findings are highly qualitative and declarations of success may be inconsistent with those findings.

REMS assessments should be designed in a meaningful manner for measuring specific objectives.  It’s important to start with a rational design – balance the interests of regulators, customers, and manufacturers.  The design should be evidence-based and include end users in the design process.  (more…)